An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Conclude your understanding of lymphoma with an in-depth look at its signs and symptoms, from common indicators to subtle clues.

Speaker : Dr Suvir Singh

Optimizing Treatment Options in Advanced Urothelial Carcinoma

Explore Dr. TamoJit Chaudhury’s expert insights on optimizing advanced urothelial carcinoma treatment, covering immunotherapy, targeted therapy, and clinical trial breakthroughs.

Speakers : Dr. Tamojit Chaudhury

Updates on the First Line Management of ALK+ NSCLC

In this webinar, a detailed discussion is done on Enhancing Outcomes in Advanced Lung Cancer

Speakers : Prof. Tony Mok

Managing ALK+ NSCLC while Ensuring Long-Term Safety of the Patients

Join Prof. Jessica Lin as she explores key strategies for managing ALK+ NSCLC while prioritizing long-term patient safety

Speakers : Prof. Jessica Lin

Post Progression Approaches After First-line Third-Generaion ALK Inhibitors

Join Prof. Solange Peters as she explores post-progression strategies after first-line third-generation ALK inhibitors in NSCLC.

Speakers : Prof. Solange Peters

Oropharyngeal Cancer in Relation to HPV Status

Learn about the occurrence of oropharyngeal cancer in HPV negative patients through different case presentations.

Speakers : Dr. Ashish M Kaushal

Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma

Dr. Rohit R Pai compares Nimotuzumab plus chemoradiotherapy vs. placebo plus chemoradiotherapy in locally advanced nasopharyngeal carcinoma (LA-NPC).

Speakers : Dr. Rohit R Pai - Speaker

Role of Nimotuzumab in Management of Nasopharyngeal Cancer

Explore the role of Nimotuzumab in Nasopharyngeal Cancer management with Dr. Abhishek Raj, focusing on targeted therapy and improved patient outcomes.

Speakers : Dr. Abhishek Raj

Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World

Explore the benefits of CDK4/6 inhibitors in HR+/HER2- advanced breast cancer with Dr. Shailesh Bondarde.

Speakers : Dr Shailesh Bondarde

Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients

Discover how CDK4/6 inhibitors extend progression-free survival (PFS) and overall survival (OS) in HR+/HER2- metastatic breast cancer (mBC) patients.

Speakers : Dr Parveen Jain

First-Line Maintenance Therapy for Metastatic Urothelial Carcinoma: Bridging Clinical Practice and Trials

Explore expert insights on first-line maintenance therapy for metastatic urothelial carcinoma in this panel discussion featuring Dr. Tushar Patil, Dr. Varun Nagori, and Dr. Amol Dongre.

Speakers : Dr Tushar Patil ,Dr Varun Nagori ,Dr Amol Dongre


Recommended News For You

Combination of significant weight gain and late motherhood greatly increases risk of breast cancer, study finds

Renewing the call for a national Cancer Patient's Bill of Rights

Which Salvage Therapy Is Best for Recurrent Prostate Cancer?

For patients with prostate cancer, long-term follow-up helps identify treatment side effects.

An Eye Surgeon's Unexpected Discovery of the "Before and After".

PSMA-PET/CT Detects Metastatic Prostate Cancer Missed by Other Imaging

AI innovation unlocks non-surgical way to detect brain cancer spread

Recommended Articles For You

Unveiling the Mysteries of Smudge Cells: A New Frontier in Cellular Biology 

Liquid Biopsy: A Revolutionary Tool for Early Detection and Monitoring of Colorectal Cancer 

Unveiling the Hidden Mechanisms of Hemolytic Reactions 

Unlocking the Mysteries of Rhabdomyoma: A New Hope for Treatment 
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

The acceptance of innovative hormonal therapy for advanced prostate cancer is racialized.

2.

Disparities in use of MRI to detect prostate cancer: Race and location may influence testing

3.

For patients with prostate cancer, long-term follow-up helps identify treatment side effects.

4.

Progress in Early Cancer Diagnosis; Breast Cancer in Younger Women; Diet and Cancer.

5.

ASCO: Vepdegestrant ups survival in ER+, HER2− advanced breast cancer with ESR1 mutations

1.

Managing Hematoma: A Guide to Prevention and Treatment

2.

The Importance of Early Detection: How Genetics Play a Role in Leucocythemia Diagnosis 

3.

Anion Gap: The Simple Calculation That Reveals Much About Your Health 

4.

Exploring the Benefits of Endari: How This Natural Remedy Can Help You Live a Healthier Life

5.

Uncovering the Causes of Thrombocytosis: A Journey to Improved Health

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment

2.

Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases

3.

The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion

4.

Thromboprophylaxis In Medical Settings

5.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot